Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer
1NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia;2Sydney Cancer Centre – Royal Prince Alfred and Concord Hospitals, Sydney, NSW, Australia;3International Breast Cancer Study Group, Bern, Switzerland